Spots Global Cancer Trial Database for aggressive systemic mastocytosis (asm)
Every month we try and update this database with for aggressive systemic mastocytosis (asm) cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
A Safety, Tolerability and PK Study of DCC-2618 in Patients With Advanced Malignancies | NCT02571036 | Gastrointestina... Advanced System... Advanced Cancer... | DCC-2618 DCC-2618 | 18 Years - | Deciphera Pharmaceuticals LLC | |
Patient-Reported Outcome Questionnaire for Systemic Mastocytosis | NCT02380222 | Aggressive Syst... SM w Assoc Clon... Mast Cell Leuke... Smoldering Syst... Indolent System... | Interview | 18 Years - | Adelphi Values LLC | |
A Safety, Tolerability and PK Study of DCC-2618 in Patients With Advanced Malignancies | NCT02571036 | Gastrointestina... Advanced System... Advanced Cancer... | DCC-2618 DCC-2618 | 18 Years - | Deciphera Pharmaceuticals LLC | |
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis | NCT04996875 | Advanced System... SM With an Asso... Mast Cell Leuke... Aggressive Syst... | bezuclastinib | 18 Years - | Cogent Biosciences, Inc. | |
Patient-Reported Outcome Questionnaire for Systemic Mastocytosis | NCT02380222 | Aggressive Syst... SM w Assoc Clon... Mast Cell Leuke... Smoldering Syst... Indolent System... | Interview | 18 Years - | Adelphi Values LLC | |
Patient-Reported Outcome Questionnaire for Systemic Mastocytosis | NCT02380222 | Aggressive Syst... SM w Assoc Clon... Mast Cell Leuke... Smoldering Syst... Indolent System... | Interview | 18 Years - | Adelphi Values LLC |